Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients

The epidermal growth factor receptor (EGFR) mutation status in the tyrosine kinase domain is known to be a predictor of the response to gefitinib or erlotinib in lung cancer; thus, a non-surgical procedure of tumor specimen collection is critical for mutation analysis. The aim of the present study w...

Descripción completa

Detalles Bibliográficos
Autores principales: LEWANDOWSKA, MARZENA ANNA, JÓŹWICKI, WOJCIECH, JOCHYMSKI, CEZARY, KOWALEWSKI, JANUSZ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783057/
https://www.ncbi.nlm.nih.gov/pubmed/23817662
http://dx.doi.org/10.3892/or.2013.2579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783057/
https://www.ncbi.nlm.nih.gov/pubmed/23817662
http://dx.doi.org/10.3892/or.2013.2579

Ejemplares similares